Product NDC: | 50458-920 |
Proprietary Name: | LEVAQUIN |
Non Proprietary Name: | levofloxacin |
Active Ingredient(s): | 250 mg/1 & nbsp; levofloxacin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50458-920 |
Labeler Name: | Janssen Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020634 |
Marketing Category: | NDA |
Start Marketing Date: | 19961220 |
Package NDC: | 50458-920-10 |
Package Description: | 10 BLISTER PACK in 1 CARTON (50458-920-10) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Code | 50458-920-10 |
Proprietary Name | LEVAQUIN |
Package Description | 10 BLISTER PACK in 1 CARTON (50458-920-10) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
Product NDC | 50458-920 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levofloxacin |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19961220 |
Marketing Category Name | NDA |
Labeler Name | Janssen Pharmaceuticals, Inc. |
Substance Name | LEVOFLOXACIN |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |